MarkAndrewJacobsonMD

Grant Support

• HIV Epitope Specific T Cell Responses And Control Of HIV ReplicationNational Institute Of Allergy And Infectious Diseases2007–2008
• Aberrant T Cell Function And Immunopathogenesis Of CMV Immune Recovery UveitisNational Eye Institute2007–2008
• The Role Of Protein Loop Flexibility In Substrate BindingNational Center For Research Resources2006
• The Role Of Protein Loop Flexibility In Substrate BindingNational Center For Research Resources2005
• CMV Immune Response &Long-Term Outcome Of CMV RetinitisNational Eye Institute2004–2005
• Adjuvant Rhil-12 With A CytomegalovirusNational Center For Research Resources2004–2005
• Aactg 5079: Physiologic TestosteroneNational Center For Research Resources2004–2005
• ACTG 5077: Haart/Hiv CompartmentsNational Center For Research Resources2004
• Aactg A5082: Metformin/ RosiglitazoneNational Center For Research Resources2004
• A5159: HIV Protease Inhibitors And Calcium Channel BlockersNational Center For Research Resources2004
• Adjunct Rhil-12 Enhance Thi Response To Viral Vaccine?National Institute Of Allergy And Infectious Diseases2002–2004
• Salvage Antiretroviral Therapy For HIV+ PatientsNational Center For Research Resources2000–2002
• Quadruple Drug Treatment With 3tc/Zdv PLUS ABC PLUS APV In HIV InfectionNational Center For Research Resources2000–2002
• PI And NRTI In HIV TherapyNational Center For Research Resources2000–2002
• Phase I Trial Of IL-12 In HIV Infected SubjectsNational Center For Research Resources2000–2002
• Interaction Between PI And Lipid Lowering AgentsNational Center For Research Resources2000–2002
• HIV Protease Inhibitors And Methadone Metabolism In HIV+ SubjectsNational Center For Research Resources2000–2002
• Dmp-266 Or Nfv PLUS Combivir And Indinavir In HIVNational Center For Research Resources2000–2002
• Discontinuing Therapy For Disseminated MACNational Center For Research Resources2000–2002
• Amprenavir As PART Of Dual Protease Inhibitor RegimensNational Center For Research Resources2000–2002
• Core--ClinicalNational Institute Of Mental Health1998–2001
• Adult AIDS Clinical Trials UnitNational Institute Of Allergy And Infectious Diseases1992–2001
• ACTG 387: Paired Combinations Of Nelfinavir, Ritonavir, &SaquinavirNational Center For Research Resources1999–2000
• Safety, Tolerance And Activity On Plasma Viremia Of SCH 52000 In HIVNational Center For Research Resources1998–2000
• Trial To Evaluate Tolerability, Anti CMV Activity/Pharmacokinetics Of 1263w94National Center For Research Resources1997–2000
• Fluconazole, Clarithromycin, Rifabutin/Sulfamethoxazole And DapsoneNational Center For Research Resources1997–1999
• Women'S Health AgendaNational Institute Of Allergy And Infectious Diseases1996–1999
• Pharmacology AgendaNational Institute Of Allergy And Infectious Diseases1996–1999
• Outreach AgendaNational Institute Of Allergy And Infectious Diseases1996–1999
• Outcomes Committee AgendaNational Institute Of Allergy And Infectious Diseases1996–1999
• Neurology AgendaNational Institute Of Allergy And Infectious Diseases1996–1999
• Immunology And Immune Based Therapy AgendaNational Institute Of Allergy And Infectious Diseases1996–1999
• HIV Disease Research AgendaNational Institute Of Allergy And Infectious Diseases1996–1999
• Core--Advanced Technology LaboratoriesNational Institute Of Allergy And Infectious Diseases1996–1999
• Complications Of HIV Disease AgendaNational Institute Of Allergy And Infectious Diseases1996–1999
• Core--ClinicalNational Institute Of Allergy And Infectious Diseases1994–1998
• Oral Ganciclovir After Treatment With IV Ganciclovir For CMV GI DiseaseNational Center For Research Resources1996–1997
• Hpmpc Peripheral CMV Retinitis TrialNational Center For Research Resources1996–1997
• Recombinant Human Interleukin 12 In HIV Infected Subjects--301 To 500 CD4 CellsNational Center For Research Resources1996
• Recombinant Human Interleukin 12 In HIV Infected Subjects--100 To 300 CD4 CellsNational Center For Research Resources1996
• Recombinant Human Interleukin 12 In HIV Infected Subjects (301-500 CD4 Cells)National Center For Research Resources1995
• Recombinant Human Interleukin 12 In HIV Infected Subjects (100-300 CD4 Cells)National Center For Research Resources1995
• AIDS Clinical TrialsNational Institute Of Allergy And Infectious Diseases1994–1995